KIR3DL2 and hepatocellular carcinoma: Combining this with Kaplan-Meier results from TCGA database regarding KIR3DL2 in HCC patients, we propose that assessing KIR3DL2 expression on peripheral blood NK cells could serve as a potential prognostic marker for HCC patients.